DST-backed researchers from Pune demonstrate targeted gene-silencing approach that significantly inhibits tumor growth with minimal toxicity
Day-care model aimed at providing specialized psychological support for women during pregnancy and motherhood
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
The filing is backed by Phase III data from the lidERA Breast Cancer study
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
The facility sets a new benchmark in respiratory diagnostics
Subscribe To Our Newsletter & Stay Updated
